Black Diamond Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
VERSANT VENTURE CAPITAL VI, L.P. 10 percent owner
 Common Stock 221,600 $6.32 $1,400,512
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 400,000 $2.34 $934,000
Purchase
RA CAPITAL MANAGEMENT, L.P. director
 Common Stock 935,850 $5 $4,679,250
Purchase
BEHBAHANI ALI director
 Common Stock 1,000,000 $5 $5,000,000
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 1,000,000 $5 $5,000,000
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 1,740,000 $5.49 $9,554,340
Sale
EPSTEIN DAVID M. director, officer: SEE REMARKS
 Common Stock 25,000 $6.7 $167,500
Purchase
NI FANG officer: SEE REMARKS
 Common Stock 36,363 $1.28 $46,581
Purchase
NI FANG officer: SEE REMARKS
 Common Stock 20,000 $1.29 $25,780
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 99,801 $2.25 $224,951
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 172,974 $2.18 $376,910
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 191,678 $1.87 $359,205
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 87,850 $1.51 $132,741
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 53,734 $1.42 $76,356
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 77,689 $1.32 $102,783
Purchase
NI FANG officer: SEE REMARKS
 Common Stock 25,000 $2.44 $61,025
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 255,711 $2.57 $657,944
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 150,000 $2.66 $399,450
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 150,000 $3.24 $486,600
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 150,000 $3.29 $493,950
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 102,556 $3.57 $366,227
Purchase
BIOTECH GROWTH N V 10 percent owner
 Common Stock 150,000 $3.42 $513,600
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $3.2 $13,050
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $27.4 $111,754
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 4,078 $3.2 $13,050
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $27.4 $111,754
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $10.86 $27,150
Sale
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $10.86 $27,150
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Stock Option (Right to Buy) 2,500 $10.86 $27,150
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $25 $101,950
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $25 $101,950
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 179,915 $3.2 $575,728
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 N/A N/A
Sale
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 N/A N/A
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Stock Option (Right to Buy) 2,500 N/A N/A
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $3.2 $13,050
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $3.2 $13,050
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 4,078 $3.2 $13,050
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 N/A N/A
Sale
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 N/A N/A
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Stock Option (Right to Buy) 2,500 $10.86 $27,150
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $27.43 $111,843
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $27.43 $111,843
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Stock Option (Right to Buy) 4,078 $3.2 $13,050
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 4,078 $3.2 $13,050
Sale
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $10.86 $27,150
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Common Stock 2,500 $10.86 $27,150
Option
ROBERTS CHRISTOPHER D. officer: Chief Scientific Officer
 Stock Option (Right to Buy) 2,500 $10.86 $27,150
Option
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 11,578 $7.03 $81,393
Sale
HATZIS-SCHOCH BRENT officer: See Remarks
 Common Stock 11,578 $32.49 $376,204

Showing 1 to 50 of 190 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: